Management of Depression in Adults: A Review
- PMID: 38856993
- DOI: 10.1001/jama.2024.5756
Management of Depression in Adults: A Review
Erratum in
-
Error in Discussion Section.JAMA. 2024 Oct 15;332(15):1306. doi: 10.1001/jama.2024.18427. JAMA. 2024. PMID: 39283614 Free PMC article. No abstract available.
Abstract
Importance: Approximately 9% of US adults experience major depression each year, with a lifetime prevalence of approximately 17% for men and 30% for women.
Observations: Major depression is defined by depressed mood, loss of interest in activities, and associated psychological and somatic symptoms lasting at least 2 weeks. Evaluation should include structured assessment of severity as well as risk of self-harm, suspected bipolar disorder, psychotic symptoms, substance use, and co-occurring anxiety disorder. First-line treatments include specific psychotherapies and antidepressant medications. A network meta-analysis of randomized clinical trials reported cognitive therapy, behavioral activation, problem-solving therapy, interpersonal therapy, brief psychodynamic therapy, and mindfulness-based psychotherapy all had at least medium-sized effects in symptom improvement over usual care without psychotherapy (standardized mean difference [SMD] ranging from 0.50 [95% CI, 0.20-0.81] to 0.73 [95% CI, 0.52-0.95]). A network meta-analysis of randomized clinical trials reported 21 antidepressant medications all had small- to medium-sized effects in symptom improvement over placebo (SMD ranging from 0.23 [95% CI, 0.19-0.28] for fluoxetine to 0.48 [95% CI, 0.41-0.55] for amitriptyline). Psychotherapy combined with antidepressant medication may be preferred, especially for more severe or chronic depression. A network meta-analysis of randomized clinical trials reported greater symptom improvement with combined treatment than with psychotherapy alone (SMD, 0.30 [95% CI, 0.14-0.45]) or medication alone (SMD, 0.33 [95% CI, 0.20-0.47]). When initial antidepressant medication is not effective, second-line medication treatment includes changing antidepressant medication, adding a second antidepressant, or augmenting with a nonantidepressant medication, which have approximately equal likelihood of success based on a network meta-analysis. Collaborative care programs, including systematic follow-up and outcome assessment, improve treatment effectiveness, with 1 meta-analysis reporting significantly greater symptom improvement compared with usual care (SMD, 0.42 [95% CI, 0.23-0.61]).
Conclusions and relevance: Effective first-line depression treatments include specific forms of psychotherapy and more than 20 antidepressant medications. Close monitoring significantly improves the likelihood of treatment success.
Similar articles
-
Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.Cochrane Database Syst Rev. 2019 May 20;5(5):CD012855. doi: 10.1002/14651858.CD012855.pub2. Cochrane Database Syst Rev. 2019. PMID: 31106850 Free PMC article.
-
Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.Ont Health Technol Assess Ser. 2019 Feb 19;19(6):1-199. eCollection 2019. Ont Health Technol Assess Ser. 2019. PMID: 30873251 Free PMC article.
-
Interventions to improve return to work in depressed people.Cochrane Database Syst Rev. 2020 Oct 13;10(10):CD006237. doi: 10.1002/14651858.CD006237.pub4. Cochrane Database Syst Rev. 2020. PMID: 33052607 Free PMC article.
-
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.Psychopharmacol Bull. 2008;41(4):5-33. Psychopharmacol Bull. 2008. PMID: 19015627 Clinical Trial.
-
Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials.Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):293-302. doi: 10.1016/j.genhosppsych.2008.04.001. Gen Hosp Psychiatry. 2008. PMID: 18585531 Review.
Cited by
-
Association between the frequency of different modes of delivery and depression: a national cross-sectional study.Front Psychiatry. 2025 May 23;16:1595829. doi: 10.3389/fpsyt.2025.1595829. eCollection 2025. Front Psychiatry. 2025. PMID: 40485942 Free PMC article.
-
Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression.NPJ Digit Med. 2025 Aug 20;8(1):531. doi: 10.1038/s41746-025-01906-6. NPJ Digit Med. 2025. PMID: 40835713 Free PMC article.
-
Effect of bariatric surgery on nutritional and metabolic parameters: does the type of antidepressant medication matter?Eat Weight Disord. 2024 Jul 25;29(1):48. doi: 10.1007/s40519-024-01680-6. Eat Weight Disord. 2024. PMID: 39052193 Free PMC article.
-
Development and Validation of a Machine Learning Model for Predicting Long-Term Depression Risk in ACS Patients After PCI: A Retrospective Cohort Study.Int J Gen Med. 2025 Jun 8;18:2957-2972. doi: 10.2147/IJGM.S523029. eCollection 2025. Int J Gen Med. 2025. PMID: 40510255 Free PMC article.
-
Efficacy of dynamic interpersonal therapy in improving mentalising in patients with major depressive disorder and the mediating effect of mentalising on changes in depressive symptoms.Gen Psychiatr. 2025 Feb 26;38(1):e101774. doi: 10.1136/gpsych-2024-101774. eCollection 2025. Gen Psychiatr. 2025. PMID: 40017493 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical